Results 131 to 140 of about 28,830 (241)

Physiologically Based Pharmacokinetic Modeling to Assess Antiretroviral-BTK Inhibitor Interactions and Provide Recommendations for Co-Administration Regimens. [PDF]

Pharmaceutics
Chen L, Wang X, Li L, Yang Y, Liu Y, Chen W.   +5 more
europepmc   +1 more source

CYP2B6 polymorphisms and nevirapine and efavirenz DILI [PDF]

openalex   +1 more source

Efavirenz-induced skin eruption and successful desensitization

, 2002
OBJECTIVE: To report a patient with efavirenz-induced hypersensitivity syndrome reaction who was successfully desensitized to efavirenz. CASE SUMMARY: A 37-year-old HIV-positive white man was placed on efavirenz, amprenavir, stavudine, lamivudine, and ...
Phillips, E.J., Kuriakose, B., Knowles, S.R.   +2 more
core  

A Proof‐of‐Concept Study of Short‐Cycle Intermittent Antiretroviral Therapy with a Once‐Daily Regimen of Didanosine, Lamivudine, and Efavirenz for the Treatment of Chronic HIV Infection [PDF]

, 2004
Mark Dybul, Elizabeth Nies‐Kraske, Robin Dewar, Frank Maldarelli, Claire W. Hallahan, Marybeth Daucher, Stephen C. Piscitelli, Linda A. Ehler, Ann Weigand, Sarah Palmer, Julia A. Metcalf, Richard T. Davey, Diane M. Rock Kress, April Powers, Ingrid A. Beck, Lisa M. Frenkel, Michael Baseler, John M. Coffin, Anthony S. Fauci   +18 more
openalex   +1 more source

Dolutegravir in Real Life: self-reported mental and physical health outcomes after transitioning from efavirenz- to dolutegravir-based antiretroviral therapy in a prospective cohort study in Lesotho

, 2022
Jennifer Anne Brown, Bienvenu Lengo Nsakala, Kuena Mokhele, Itumeleng Rakuoane, Josephine Muhairwe, Tracy R. Glass, Alain Amstutz, Nadine Tschumi, Jennifer M. Belus, Thomas Klimkait, Niklaus Daniel Labhardt   +10 more
openalex   +1 more source

Initiation of dolutegravir vs efavirenz on 12- and 24-month weight, body mass index, blood pressure, and incident hypertension: A target trial emulation. [PDF]

Ann Epidemiol
Zheng A, Fox MP, Greener R, Kileel EM, Bor J, Venter WD, Pisa PT, Murray EJ, Brennan AT, Maskew M.   +9 more
europepmc   +1 more source

Development and validation of methodology for HPLC-PDA for therapeutic monitoring of plasma levels of zidovudine and efavirenz

, 2009
Amanda Queiroz Soares
openalex   +1 more source

Efavirenz and CYP2C9 Genetic Polymorphisms Reduce CYP2C9 Activity in Healthy Participants. [PDF]

Clin Transl Sci
Kim JD, Metzger IF, Lu JBL, Skaar TC, Desta Z.   +4 more
europepmc   +1 more source

Neuropsychiatric complications of efavirenz in children with HIV-1 infection

, 2019
Background: Efavirenz is associated with transient neuropsychiatric manifestations but the impact on neurocognition is unknown. Genetically determined black South Africans who are slow metabolizers of efavirenz may be at risk of toxicity.
Hammond Charles
core  

Efavirenz metabolism and CNS toxicity in Ugandan children: impact of CYP2B6 genotype and plasma metabolite profiles. [PDF]

Front Pharmacol
Soeria-Atmadja S, Pettersson Bergstrand M, Amuge P, Nanzigu S, Bbuye D, Rubin J, Kekitiinwa A, Obua C, Dahl ML, Pohanka A, Gustafsson LL, Navér L, Eriksen J.   +12 more
europepmc   +1 more source